{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T14:38:26Z","timestamp":1784212706333,"version":"3.55.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T00:00:00Z","timestamp":1738713600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T00:00:00Z","timestamp":1738713600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Retin Vitr"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>To evaluate baseline optical coherence tomography (OCT) biomarkers in treatment-na\u00efve patients with neovascular age-related macular degeneration (nAMD) and their correlation with visual acuity changes following intravitreal aflibercept injections.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A retrospective analysis was conducted on treatment-na\u00efve nAMD patients. Baseline OCT biomarkers, including shallow irregular pigment epithelial detachment (SIPED), subretinal hyperreflective material, subretinal fluid, intraretinal fluid (IRF), hyperreflective foci, and subretinal drusenoid deposits, were assessed. Patients received bimonthly aflibercept injections after three loading doses. Visual acuity changes were evaluated at 3 and 12 months. The maximum height and width of the largest pigment epithelial detachment (PED) were also measured.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Among 89 eyes with nAMD, mean best-corrected visual acuity (BCVA) improved by 6 Early Treatment Diabetic Retinopathy Study (ETDRS) letters from baseline to month 3, with sustained improvement through month 12. Baseline IRF was associated with poorer visual acuity improvement at month 12, with patients showing a mean improvement of 1.6\u2009\u00b1\u200918.2 ETDRS letters versus 11.1\u2009\u00b1\u200910 ETDRS letters in those without IRF (<jats:italic>P<\/jats:italic>\u2009=\u20090.002). Multivariable analysis indicated SIPED was linked to lower visual gains at month 3 (<jats:italic>P<\/jats:italic>\u2009=\u20090.025). The largest PED width correlated significantly with lower BCVA gains at months 3 (<jats:italic>P<\/jats:italic>\u2009=\u20090.021) and 12 (<jats:italic>P<\/jats:italic>\u2009=\u20090.043), suggesting its potential as a prognostic factor.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Baseline OCT biomarkers, including SIPED, IRF, and PED width, may predict visual acuity changes in nAMD patients treated with aflibercept, highlighting the need for individualized monitoring.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Clinical trial number<\/jats:title>\n            <jats:p>Not applicable.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s40942-025-00633-0","type":"journal-article","created":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T12:03:32Z","timestamp":1738757012000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Predictive value of different baseline optical coherence tomography biomarkers for visual acuity changes in neovascular age-related macular degeneration"],"prefix":"10.1186","volume":"11","author":[{"given":"Hamid","family":"Riazi-Esfahani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hooshang","family":"Faghihi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Bazvand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammadreza","family":"Mehrabi Bahar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan","family":"Khojasteh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Husein Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahin","family":"Faghihi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Fakhraie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Hossein","family":"Zamani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samin","family":"Ghasemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0210-2783","authenticated-orcid":false,"given":"Esmaeil","family":"Asadi Khameneh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias","family":"Khalili Pour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,5]]},"reference":[{"key":"633_CR1","doi-asserted-by":"publisher","first-page":"e106","DOI":"10.1016\/S2214-109X(13)70145-1","volume":"2","author":"WL Wong","year":"2014","unstructured":"Wong WL, Su X, Li X, Cheung CMG, Klein R, Cheng C-Y, Wong TY. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health. 2014;2:e106-116. https:\/\/doi.org\/10.1016\/S2214-109X(13)70145-1.","journal-title":"Lancet Glob Health"},{"issue":"11","key":"633_CR2","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.3390\/biom12111629","volume":"12","author":"E Rh","year":"2022","unstructured":"Rh E, Mz C, Ab S. Current and novel therapeutic approaches for treatment of neovascular age-related macular degeneration. Biomolecules. 2022;12(11):1629. https:\/\/doi.org\/10.3390\/biom12111629.","journal-title":"Biomolecules"},{"issue":"9","key":"633_CR3","doi-asserted-by":"publisher","first-page":"3049","DOI":"10.3390\/jcm12093049","volume":"12","author":"B Nawash","year":"2023","unstructured":"Nawash B, Ong J, Driban M, Hwang J, Chen J, Selvam A, Mohan S, Chhablani J. Prognostic optical coherence tomography biomarkers in neovascular age-related macular degeneration. J Clin Med. 2023;12(9):3049. https:\/\/doi.org\/10.3390\/jcm12093049.","journal-title":"J Clin Med"},{"key":"633_CR4","doi-asserted-by":"publisher","first-page":"852519","DOI":"10.3389\/fmed.2022.852519","volume":"9","author":"H Jia","year":"2022","unstructured":"Jia H, Lu B, Yuan Y, Yuan F, Li L, Song Y, Rong A, Zhou M, Wang F, Sun X. A randomized, controlled trial of treat-and-extend vs. Pro Re Nata regimen for neovascular age-related macular degeneration. Front Med. 2022;9:852519\u201329. https:\/\/doi.org\/10.3389\/fmed.2022.852519.","journal-title":"Front Med"},{"issue":"11","key":"633_CR5","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1136\/bjophthalmol-2020-317434","volume":"105","author":"V Daien","year":"2021","unstructured":"Daien V, Finger RP, Talks JS, Mitchell P, Wong TY, Sakamoto T, Eldem BM, Korobelnik J-F. Evolution of treatment paradigms in neovascular age-related macular degeneration: a review of real-world evidence. Br J Ophthalmol. 2021;105(11):1475\u20139. https:\/\/doi.org\/10.1136\/bjophthalmol-2020-317434.","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"633_CR6","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1007\/s00417-021-05384-w","volume":"260","author":"M Cozzi","year":"2022","unstructured":"Cozzi M, Monteduro D, Parrulli S, Ristoldo F, Corvi F, Zicarelli F, Staurenghi G, Invernizzi A. Prechoroidal cleft thickness correlates with disease activity in neovascular age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol. 2022;260(3):781\u20139. https:\/\/doi.org\/10.1007\/s00417-021-05384-w.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"4","key":"633_CR7","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1159\/000516108","volume":"244","author":"DT Wong","year":"2021","unstructured":"Wong DT, Berger AR, Bourgault S, Chen J, Colleaux K, Cruess AF, Dookeran RI, Gauthier D, Hurley B, Kapusta MA, Kertes PJ, Qian CX, Samad A, Sheidow T, Whelan JH. Imaging biomarkers and their impact on therapeutic decision-making in the management of neovascular age-related macular degeneration. Ophthalmologica. 2021;244(4):265\u201380. https:\/\/doi.org\/10.1159\/000516108.","journal-title":"Ophthalmologica"},{"issue":"8","key":"633_CR8","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.oret.2024.02.012","volume":"8","author":"R Karkhaneh","year":"2024","unstructured":"Karkhaneh R, Faghihi H, Riazi-Esfahani H, Abrishami M, Bazvand F, Ebrahimiadib N, Johari M, Akhlaghi M, Shoeibi N, Norouzzadeh MH, Astaneh MRA, Khojasteh H, Fooladi MI, Khodabande A, Ghassemi F, Pour EK, Zarei M, Mirshahi A, Fazel F, Ashraf H, Hosseini SM, Dourandeesh M, Feghhi M, Alizadeh Y, Behboudi H, Azadi P, Sabzvari A, Kafi H, Falavarjani KG. Evaluating the efficacy and safety of aflibercept biosimilar (P041) compared with originator product in patients with neovascular age-related macular degeneration. Ophthalmol Retina. 2024;8(8):744\u201353. https:\/\/doi.org\/10.1016\/j.oret.2024.02.012.","journal-title":"Ophthalmol Retina"},{"issue":"1","key":"633_CR9","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1038\/s41598-020-57747-8","volume":"10","author":"SC Cho","year":"2020","unstructured":"Cho SC, Ryoo NK, Ahn J, Woo SJ, Park KH. Association of irregular pigment epithelial detachment in central serous chorioretinopathy with genetic variants implicated in age-related macular degeneration. Sci Rep. 2020;10(1):1203. https:\/\/doi.org\/10.1038\/s41598-020-57747-8.","journal-title":"Sci Rep"},{"issue":"6","key":"633_CR10","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/j.ajo.2015.08.028","volume":"160","author":"KK Dansingani","year":"2015","unstructured":"Dansingani KK, Balaratnasingam C, Klufas MA, Sarraf D, Freund KB. Optical coherence tomography angiography of shallow irregular pigment epithelial detachments in pachychoroid spectrum disease. Am J Ophthalmol. 2015;160(6):1243-1254.e2. https:\/\/doi.org\/10.1016\/j.ajo.2015.08.028.","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"633_CR11","doi-asserted-by":"publisher","first-page":"134","DOI":"10.4103\/ijo.IJO_236_19","volume":"68","author":"D Alex","year":"2020","unstructured":"Alex D, Giridhar A, Gopalakrishnan M, Indu VP. Lateral elongation of flat irregular pigment epithelial detachment: a novel optical coherence tomography biomarker in polypoidal choroidal vasculopathy. Indian J Ophthalmol. 2020;68(1):134\u201340. https:\/\/doi.org\/10.4103\/ijo.IJO_236_19.","journal-title":"Indian J Ophthalmol"},{"issue":"9","key":"633_CR12","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1016\/j.ophtha.2010.01.027","volume":"117","author":"SA Zweifel","year":"2010","unstructured":"Zweifel SA, Imamura Y, Spaide TC, Fujiwara T, Spaide RF. Prevalence and significance of subretinal drusenoid deposits (reticular pseudodrusen) in age-related macular degeneration. Ophthalmology. 2010;117(9):1775\u201381. https:\/\/doi.org\/10.1016\/j.ophtha.2010.01.027.","journal-title":"Ophthalmology"},{"issue":"5","key":"633_CR13","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1038\/s41433-020-1074-y","volume":"35","author":"Y Xia","year":"2021","unstructured":"Xia Y, Feng N, Hua R. \u201cChoroidal caverns\u201d spectrum lesions. Eye. 2021;35(5):1508\u201312. https:\/\/doi.org\/10.1038\/s41433-020-1074-y.","journal-title":"Eye"},{"issue":"4","key":"633_CR14","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.oret.2022.11.006","volume":"7","author":"C Duic","year":"2023","unstructured":"Duic C, Pfau K, Keenan TDL, Wiley H, Thavikulwat A, Chew EY, Cukras C. Hyperreflective foci in age-related macular degeneration are associated with disease severity and functional impairment. Ophthalmol Retina. 2023;7(4):307\u201317. https:\/\/doi.org\/10.1016\/j.oret.2022.11.006.","journal-title":"Ophthalmol Retina"},{"issue":"5","key":"633_CR15","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.ophtha.2012.10.018","volume":"120","author":"JG Christenbury","year":"2013","unstructured":"Christenbury JG, Folgar FA, O\u2019Connell R, Chiu SJ, Farsiu S, Toth CA. Progression of intermediate age-related macular degeneration with proliferation and inner retinal migration of hyperreflective foci. Ophthalmology. 2013;120(5):1038\u201345. https:\/\/doi.org\/10.1016\/j.ophtha.2012.10.018.","journal-title":"Ophthalmology"},{"issue":"6","key":"633_CR16","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1016\/j.ophtha.2015.02.031","volume":"122","author":"TA Ciulla","year":"2015","unstructured":"Ciulla TA, Ying G-S, Maguire MG, Martin DF, Jaffe GJ, Grunwald JE, Daniel E, Toth CA, Comparison of Age-Related Macular Degeneration Treatments Trials Research Group. Influence of the vitreomacular interface on treatment outcomes in the comparison of age-related macular degeneration treatments trials. Ophthalmology. 2015;122(6):1203\u201311. https:\/\/doi.org\/10.1016\/j.ophtha.2015.02.031.","journal-title":"Ophthalmology"},{"key":"633_CR17","doi-asserted-by":"publisher","first-page":"9640131","DOI":"10.1155\/2018\/9640131","volume":"2018","author":"X Zhang","year":"2018","unstructured":"Zhang X, Lai TYY. Baseline predictors of visual acuity outcome in patients with wet age-related macular degeneration. BioMed Res Int. 2018;2018:9640131. https:\/\/doi.org\/10.1155\/2018\/9640131.","journal-title":"BioMed Res Int"},{"issue":"1","key":"633_CR18","doi-asserted-by":"publisher","first-page":"19513","DOI":"10.1038\/s41598-023-46891-6","volume":"13","author":"H Riazi-Esfahani","year":"2023","unstructured":"Riazi-Esfahani H, Khameneh EA, Ghassemi F, Bahar MM, Torkashvand A, Mahmoudi A, Ahmed AH, Faghihi S, Rahimi M, Akbarzadeh A, Faghihi H, Pour EK. Pachychoroid neovasculopathy versus macular neovascularization in age-related macular degeneration with and without shallow irregular pigment epithelial detachment. Sci Rep. 2023;13(1):19513\u20139. https:\/\/doi.org\/10.1038\/s41598-023-46891-6.","journal-title":"Sci Rep"},{"issue":"9","key":"633_CR19","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1016\/j.ophtha.2013.01.073","volume":"120","author":"GJ Jaffe","year":"2013","unstructured":"Jaffe GJ, Martin DF, Toth CA, Daniel E, Maguire MG, Ying G-S, Grunwald JE, Huang J. Macular morphology and visual acuity in the comparison of age-related macular degeneration treatments trials (CATT). Ophthalmology. 2013;120(9):1860\u201370. https:\/\/doi.org\/10.1016\/j.ophtha.2013.01.073.","journal-title":"Ophthalmology"},{"issue":"12","key":"633_CR20","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1136\/bjophthalmol-2014-30518619","volume":"98","author":"M Ritter","year":"2014","unstructured":"Ritter M, Simader C, Bolz M, De\u00e1k GG, Mayr-Sponer U, Sayegh R, Kundi M, Schmidt-Erfurth UM. Intraretinal cysts are the most relevant prognostic biomarker in neovascular age-related macular degeneration independent of the therapeutic strategy. Br J Ophthalmol. 2014;98(12):1629\u201335. https:\/\/doi.org\/10.1136\/bjophthalmol-2014-30518619.","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"633_CR21","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/j.ophtha.2015.12.002","volume":"123","author":"S Sharma","year":"2016","unstructured":"Sharma S, Toth CA, Daniel E, Grunwald JE, Maguire MG, Ying G-S, Huang J, Martin DF, Jaffe GJ. Macular morphology and visual acuity in the second year of the comparison of age-related macular degeneration treatments trials. Ophthalmology. 2016;123(4):865\u201375. https:\/\/doi.org\/10.1016\/j.ophtha.2015.12.002.","journal-title":"Ophthalmology"},{"issue":"2","key":"633_CR22","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.ophtha.2018.08.035","volume":"126","author":"GJ Jaffe","year":"2019","unstructured":"Jaffe GJ, Ying G-S, Toth CA, Daniel E, Grunwald JE, Martin DF, Maguire MG. Macular morphology and visual acuity in year five of the comparison of age-related macular degeneration treatments trials (CATT). Ophthalmology. 2019;126(2):252\u201360. https:\/\/doi.org\/10.1016\/j.ophtha.2018.08.035.","journal-title":"Ophthalmology"},{"issue":"3","key":"633_CR23","doi-asserted-by":"publisher","first-page":"238","DOI":"10.22336\/rjo.2019.36","volume":"63","author":"S Inan","year":"2019","unstructured":"Inan S, Polat O, Karadas M, Inan UU. The association of exudation pattern with anatomical and functional outcomes in patients with Neovascular Age-Related Macular Degeneration. Romanian J Ophthalmol. 2019;63(3):238.","journal-title":"Romanian J Ophthalmol"},{"issue":"4","key":"633_CR24","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1097\/IAE.0000000000003283","volume":"42","author":"V Chaudhary","year":"2022","unstructured":"Chaudhary V, Matonti F, Zarranz-Ventura J, Stewart MW. Impact of fluid compartments on functional outcomes for patients with neovascular age-related macular degeneration: a systematic literature review. Retina Phila Pa. 2022;42(4):589\u2013606. https:\/\/doi.org\/10.1097\/IAE.0000000000003283.","journal-title":"Retina Phila Pa"},{"issue":"6","key":"633_CR25","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1167\/iovs.63.6.17","volume":"63","author":"JP Ehlers","year":"2022","unstructured":"Ehlers JP, Patel N, Kaiser PK, Heier JS, Brown DM, Meng X, Reese J, Lunasco L, Le TK, Ming Hu, Srivastava SK. The association of fluid volatility with subretinal hyperreflective material and ellipsoid zone integrity in neovascular AMD. Invest Ophthalmol Vis Sci. 2022;63(6):17. https:\/\/doi.org\/10.1167\/iovs.63.6.17.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"633_CR26","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/j.oret.2024.02.010","volume":"8","author":"JP Ehlers","year":"2024","unstructured":"Ehlers JP, Lunasco LM, Yordi S, Cetin H, Le TK, Sarici K, Kaiser PK, Khanani AM, Talcott KE, Hu J, Meng X, Srivastava SK. Compartmental exudative dynamics in neovascular age-related macular degeneration: volumetric outcomes and impact of volatility in a phase III clinical trial. Ophthalmol Retina. 2024;8(8):765\u201377. https:\/\/doi.org\/10.1016\/j.oret.2024.02.010.","journal-title":"Ophthalmol Retina"},{"issue":"6","key":"633_CR27","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1136\/bjo-2023-323577","volume":"108","author":"S Sadda","year":"2024","unstructured":"Sadda S, Sarraf D, Khanani AM, Tadayoni R, Chang AA, Saffar I, Gedif K, Wong DT. Comparative assessment of subretinal hyper-reflective material in patients treated with brolucizumab versus aflibercept in HAWK and HARRIER. Br J Ophthalmol. 2024;108(6):852\u20138. https:\/\/doi.org\/10.1136\/bjo-2023-323577.","journal-title":"Br J Ophthalmol"},{"issue":"7","key":"633_CR28","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1097\/IAE.0000000000000130","volume":"34","author":"E Rahimy","year":"2014","unstructured":"Rahimy E, Freund KB, Larsen M, Spaide RF, Costa RA, Hoang Q, Christakopoulos C, Munch IC, Sarraf D. Multilayered pigment epithelial detachment in neovascular age-related macular degeneration. Retina. 2014;34(7):1289\u201395. https:\/\/doi.org\/10.1097\/IAE.0000000000000130.","journal-title":"Retina"},{"issue":"1","key":"633_CR29","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s40942-022-00379-z","volume":"8","author":"R Hayashi-Mercado","year":"2022","unstructured":"Hayashi-Mercado R, P\u00e9rez-Monta\u00f1o C, Reyes-S\u00e1nchez J, Ram\u00edrez-Estudillo A. Findings of uncertain significance by optical coherence tomography (OCT) as prognostic factors in neovascular age-related macular degeneration (nAMD) treated with ranibizumab. Int J Retina Vitr. 2022;8(1):29. https:\/\/doi.org\/10.1186\/s40942-022-00379-z.","journal-title":"Int J Retina Vitr"},{"issue":"3","key":"633_CR30","doi-asserted-by":"publisher","first-page":"e338","DOI":"10.1111\/aos.15273","volume":"101","author":"G Kredi","year":"2023","unstructured":"Kredi G, Iglicki M, Gomel N, Hilely A, Loewenstein A, Habot-Wilner Z, Zur D. Risk factors and clinical significance of prechoroidal cleft in eyes with neovascular age-related macular degeneration in Caucasian patients. Acta Ophthalmol (Copenh). 2023;101(3):e338\u201345. https:\/\/doi.org\/10.1111\/aos.15273.","journal-title":"Acta Ophthalmol (Copenh)"},{"issue":"11","key":"633_CR31","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1097\/IAE.0000000000001435","volume":"37","author":"JM Kim","year":"2017","unstructured":"Kim JM, Kang SW, Son DY, Bae K. Risk factors and clinical significance of prechoroidal cleft in neovascular age-related macular degeneration. Retina. 2017;37(11):2047\u201355. https:\/\/doi.org\/10.1097\/IAE.0000000000001435.","journal-title":"Retina"},{"issue":"11","key":"633_CR32","doi-asserted-by":"publisher","first-page":"2983","DOI":"10.1038\/s41433-020-01354-4","volume":"35","author":"U Chakravarthy","year":"2021","unstructured":"Chakravarthy U, Havilio M, Syntosi A, Pillai N, Wilkes E, Benyamini G, Best C, Sagkriotis A. Impact of macular fluid volume fluctuations on visual acuity during anti-VEGF therapy in eyes with nAMD. Eye Lond Engl. 2021;35(11):2983\u201390. https:\/\/doi.org\/10.1038\/s41433-020-01354-4.","journal-title":"Eye Lond Engl"},{"issue":"7","key":"633_CR33","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1016\/j.ophtha.2016.03.037","volume":"123","author":"SM Waldstein","year":"2016","unstructured":"Waldstein SM, Simader C, Giovanni Staurenghi N, Chong V, Mitchell P, Jaffe GJ, Chengxing Lu, Katz TA, Schmidt-Erfurth U. Morphology and visual acuity in aflibercept and ranibizumab therapy for neovascular age-related macular degeneration in the VIEW trials. Ophthalmology. 2016;123(7):1521\u20139. https:\/\/doi.org\/10.1016\/j.ophtha.2016.03.037.","journal-title":"Ophthalmology"},{"issue":"6","key":"633_CR34","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1016\/j.ophtha.2013.12.029","volume":"121","author":"C Simader","year":"2014","unstructured":"Simader C, Ritter M, Bolz M, De\u00e1k GG, Mayr-Sponer U, Golbaz I, Kundi M, Schmidt-Erfurth UM. Morphologic parameters relevant for visual outcome during anti-angiogenic therapy of neovascular age-related macular degeneration. Ophthalmology. 2014;121(6):1237\u201345. https:\/\/doi.org\/10.1016\/j.ophtha.2013.12.029.","journal-title":"Ophthalmology"},{"issue":"4","key":"633_CR35","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.ophtha.2014.11.017","volume":"122","author":"U Schmidt-Erfurth","year":"2015","unstructured":"Schmidt-Erfurth U, Waldstein SM, Deak G-G, Kundi M, Simader C. Pigment epithelial detachment followed by retinal cystoid degeneration leads to vision loss in treatment of neovascular age-related macular degeneration. Ophthalmology. 2015;122(4):822\u201332. https:\/\/doi.org\/10.1016\/j.ophtha.2014.11.017.","journal-title":"Ophthalmology"},{"issue":"1","key":"633_CR36","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/s41598-018-36704-6","volume":"9","author":"T-T Lai","year":"2019","unstructured":"Lai T-T, Hsieh Y-T, Yang C-M, Ho T-C, Yang C-H. Biomarkers of optical coherence tomography in evaluating the treatment outcomes of neovascular age-related macular degeneration: a real-world study. Sci Rep. 2019;9(1):529. https:\/\/doi.org\/10.1038\/s41598-018-36704-6.","journal-title":"Sci Rep"},{"issue":"9","key":"633_CR37","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1136\/bjophthalmol-2013-304670","volume":"98","author":"M Suzuki","year":"2014","unstructured":"Suzuki M, Nagai N, Izumi-Nagai K, Shinoda H, Koto T, Uchida A, Mochimaru H, Yuki K, Sasaki M, Tsubota K, Ozawa Y. Predictive factors for non-response to intravitreal ranibizumab treatment in age-related macular degeneration. Br J Ophthalmol. 2014;98(9):1186. https:\/\/doi.org\/10.1136\/bjophthalmol-2013-304670.","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"633_CR38","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1007\/s00417-013-2519-9","volume":"252","author":"L Ersoy","year":"2014","unstructured":"Ersoy L, Ristau T, Kirchhof B, Liakopoulos S. Response to anti-VEGF therapy in patients with subretinal fluid and pigment epithelial detachment on spectral-domain optical coherence tomography. Graefes Arch Clin Exp Ophthalmol Albrecht Von Graefes Arch Klin Exp Ophthalmol. 2014;252(6):889\u201397. https:\/\/doi.org\/10.1007\/s00417-013-2519-9.","journal-title":"Graefes Arch Clin Exp Ophthalmol Albrecht Von Graefes Arch Klin Exp Ophthalmol"},{"issue":"2","key":"633_CR39","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1159\/000337251","volume":"228","author":"T Baba","year":"2012","unstructured":"Baba T, Kitahashi M, Kubota-Taniai M, Oshitari T, Yamamoto S. Two-year course of subfoveal pigment epithelial detachment in eyes with age-related macular degeneration and visual acuity better than 20\/40. Ophthalmol J Int Ophtalmol Int J Ophthalmol Z Augenheilkd. 2012;228(2):102\u20139. https:\/\/doi.org\/10.1159\/000337251.","journal-title":"Ophthalmol J Int Ophtalmol Int J Ophthalmol Z Augenheilkd"},{"issue":"11","key":"633_CR40","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1007\/s00417-011-1734-5","volume":"249","author":"A Mariani","year":"2011","unstructured":"Mariani A, Deli A, Ambresin A, Mantel I. Characteristics of eyes with secondary loss of visual acuity receiving variable dosing ranibizumab for neovascular age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol Albrecht Von Graefes Arch Klin Exp Ophthalmol. 2011;249(11):1635\u201342. https:\/\/doi.org\/10.1007\/s00417-011-1734-5.","journal-title":"Graefes Arch Clin Exp Ophthalmol Albrecht Von Graefes Arch Klin Exp Ophthalmol"},{"issue":"6","key":"633_CR41","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1136\/bjo.2006.102467","volume":"91","author":"M Bolz","year":"2007","unstructured":"Bolz M, Michels S, Geitzenauer W, Prager F, Schmidt-Erfurth U. Effect of systemic bevacizumab therapy on retinal pigment epithelial detachment. Br J Ophthalmol. 2007;91(6):785\u20139. https:\/\/doi.org\/10.1136\/bjo.2006.102467.","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"633_CR42","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.survophthal.2020.05.003","volume":"66","author":"KX Cheong","year":"2021","unstructured":"Cheong KX, Teo KYC, Cheung CMG. Influence of pigment epithelial detachment on visual acuity in neovascular age-related macular degeneration. Surv Ophthalmol. 2021;66(1):68\u201397. https:\/\/doi.org\/10.1016\/j.survophthal.2020.05.003.","journal-title":"Surv Ophthalmol"},{"issue":"1","key":"633_CR43","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1097\/IAE.0000000000003935","volume":"44","author":"D Sarraf","year":"2024","unstructured":"Sarraf D, Khanani AM, Sadda SR, Chang A, Wong DT, Kempf A-S, Saffar I, Tang S, Tadayoni R. Pigment epithelial detachment thickness and variability affects visual outcomes in patients with neovascular age-related macular degeneration. Retina. 2024;44(1):10. https:\/\/doi.org\/10.1097\/IAE.0000000000003935.","journal-title":"Retina"},{"issue":"1","key":"633_CR44","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12886-023-02797-5","volume":"23","author":"Y Shu","year":"2023","unstructured":"Shu Y, Ye F, Liu H, Wei J, Sun X. Predictive value of pigment epithelial detachment markers for visual acuity outcomes in neovascular age-related macular degeneration. BMC Ophthalmol. 2023;23(1):83. https:\/\/doi.org\/10.1186\/s12886-023-02797-5.","journal-title":"BMC Ophthalmol"},{"issue":"1","key":"633_CR45","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s12886-018-0824-0","volume":"18","author":"P Tyagi","year":"2018","unstructured":"Tyagi P, Juma Z, Hor YK, Scott NW, Ionean A, Santiago C. Clinical response of pigment epithelial detachment associated with neovascular age-related macular degeneration in switching treatment from Ranibizumab to Aflibercept. BMC Ophthalmol. 2018;18(1):148. https:\/\/doi.org\/10.1186\/s12886-018-0824-0.","journal-title":"BMC Ophthalmol"},{"issue":"12","key":"633_CR46","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1038\/s41433-020-0803-6","volume":"34","author":"KX Cheong","year":"2020","unstructured":"Cheong KX, Grewal DS, Teo KYC, Gan ATL, Jaffe GJ, Cheung GCM. The relationship between pigment epithelial detachment and visual outcome in neovascular age-related macular degeneration and polypoidal choroidal vasculopathy. Eye Lond Engl. 2020;34(12):2257\u201363. https:\/\/doi.org\/10.1038\/s41433-020-0803-6.","journal-title":"Eye Lond Engl"},{"issue":"14","key":"633_CR47","doi-asserted-by":"publisher","first-page":"6038","DOI":"10.1167\/iovs.17-22378","volume":"58","author":"AV Zarubina","year":"2017","unstructured":"Zarubina AV, Gal-Or O, Huisingh CE, Owsley C, Freund KB. Macular atrophy development and subretinal drusenoid deposits in anti-vascular endothelial growth factor treated age-related macular degeneration. Invest Ophthalmol Vis Sci. 2017;58(14):6038. https:\/\/doi.org\/10.1167\/iovs.17-22378.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10","key":"633_CR48","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1016\/j.ophtha.2020.03.031","volume":"127","author":"SR Sadda","year":"2020","unstructured":"Sadda SR, Abdelfattah NS, Lei J, Shi Y, Marion KM, Morgenthien E, Gune S, Balasubramanian S. Spectral-domain OCT analysis of risk factors for macular atrophy development in the HARBOR study for neovascular age-related macular degeneration. Ophthalmology. 2020;127(10):1360\u201370. https:\/\/doi.org\/10.1016\/j.ophtha.2020.03.031.","journal-title":"Ophthalmology"},{"issue":"6","key":"633_CR49","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1089\/jop.2015.0125","volume":"32","author":"W Kikushima","year":"2016","unstructured":"Kikushima W, Sakurada Y, Sugiyama A, Tanabe N, Kume A, Iijima H. Factors predictive of visual outcome 1 year after intravitreal aflibercept injection for typical neovascular age-related macular degeneration. J Ocul Pharmacol Ther Off J Assoc Ocul Pharmacol Ther. 2016;32(6):376\u201382. https:\/\/doi.org\/10.1089\/jop.2015.0125.","journal-title":"J Ocul Pharmacol Ther Off J Assoc Ocul Pharmacol Ther"},{"issue":"1","key":"633_CR50","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1097\/IAE.0000000000001134","volume":"37","author":"S Nghiem-Buffet","year":"2017","unstructured":"Nghiem-Buffet S, Giocanti-Auregan A, Jung C, Dubois L, Dourmad P, Galbadon L, Fajnkuchen F, Quentel G, Cohen SY. Reticular pseudodrusen are not a predictive factor for the 1-year response to intravitreal ranibizumab in neovascular age-related macular degeneration. Retina Phila Pa. 2017;37(1):53\u20139. https:\/\/doi.org\/10.1097\/IAE.0000000000001134.","journal-title":"Retina Phila Pa"}],"container-title":["International Journal of Retina and Vitreous"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40942-025-00633-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40942-025-00633-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40942-025-00633-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T12:03:35Z","timestamp":1738757015000},"score":1,"resource":{"primary":{"URL":"https:\/\/journalretinavitreous.biomedcentral.com\/articles\/10.1186\/s40942-025-00633-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,5]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["633"],"URL":"https:\/\/doi.org\/10.1186\/s40942-025-00633-0","relation":{},"ISSN":["2056-9920"],"issn-type":[{"value":"2056-9920","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,5]]},"assertion":[{"value":"3 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the institutional review board committee of the Tehran University of Medical Sciences (Ethical code: IR.TUMS.FARABIH.REC.1401.031).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12"}}